Israeli Startup Ayala Taking BMS Cancer Drug Into Phase II With $17m Financing

 
• By Lucie Ellis-Taitt
Israeli Flag in Jerusalem, israel
Emerging Israeli biopharma flies flag for ex-BMS cancer therapy

More from Anticancer

More from Therapeutic Category